Aurinia Pharmaceuticals Inc. News - AUP

Best deals to access real time data!
TSX & TSX Venture Level 1
Monthly Subscription
for only
$25.00
TSX Level 1
Monthly Subscription
for only
$15.00
North American Extreme
Monthly Subscription
for only
$95.00
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Aurinia Pharmaceuticals AUP Toronto Common Stock CA05156V1022
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0 +0% 7.87 7.93 7.78 7.93 7.87 08:40:38
more quote information »

Recent News

Date Time Source Heading
9/19/201715:01BWAurinia to Host R&D Day and Webcast on October 20th in New..
9/08/201716:45PRNCAS&P Dow Jones Indices Announces Changes to the S&P/TSX..
9/08/201716:42PRNCAS&P Dow Jones Indices annonce des modifications aux indices..
9/05/201712:05BWAurinia to Webcast at Upcoming Investor Conferences
8/10/201715:30BWAurinia Reports Second Quarter 2017 Financial Results, and..
7/12/201720:15BWAurinia Resolves Temporary Non-Compliance with Nasdaq’s..
6/22/201715:30BWAurinia Announces Results of Annual General Meeting
6/21/201706:00BWAurinia to Host Annual General Meeting of Shareholders and..
6/16/201706:58BWVoclosporin Remission Data from the Phase IIb AURA-LV Study..
6/05/201710:27BWAurinia Presents Additional Data from Phase IIB AURA-LV..
6/05/201707:00BWAurinia Presents Additional Data from Phase Iib Aura-Lv..
5/30/201715:19BWAurinia to Participate in Late Breaking Oral Presentations..
5/17/201715:02BWAurinia Doses First Patient in AURORA Phase 3 Clinical Trial..
5/15/201707:00BWAurinia Reports First Quarter 2017 Financial Results,..
5/09/201707:00BWPharma Industry Veteran Dr. George Milne Joins Aurinia’s..
4/26/201712:03BWAurinia to Present at Bloom Burton & Co. Healthcare..
4/26/201708:17BWAurinia to Present at Bloom Burton & Co. Healthcare..
4/20/201716:00BWAurinia Releases Additional 48-Week Data from the AURA-LV..
4/17/201715:02BWAurinia Completes Licensing Deal with Merck Animal Health..
4/06/201716:12BWAurinia Announces Development Plans for Voclosporin in..
3/27/201702:30BWAurinia Highlights 48-Week Data from Open-Label AURION Study..
3/20/201715:05BWAurinia Closes US$173.1 Million Public Offering of Common..
3/16/201715:01BWAurinia Announces Presentation at 12th International..
3/14/201707:00BWAurinia Prices US$150.5 Million Public Offering of Common..
3/13/201715:01BWAurinia Announces Public Offering of Common Shares
3/09/201707:30BWAurinia Reports Fourth Quarter and Full Year 2016 Financial..
3/06/201715:05BWAurinia Announces Acceptance of Voclosporin Late-Breaking..
3/02/201712:12BWAurinia to Present at Cowen and Company 37th Annual..
3/01/201715:05BWAurinia Announces Voclosporin Meets 48-Week Remission..
2/14/201706:00BWAurinia Announces Results from Japanese Phase I Ethnic..
2/10/201713:44BWAurinia’s New CEO, Richard Glickman, to Present at Leerink..
2/06/201716:15BWAurinia Announces Appointment of Company Founder, Dr...
1/27/201707:00BWAurinia Selects Worldwide Clinical Trials as its CRO for..
1/26/201715:05BWAurinia Pharmaceuticals to Participate in Upcoming..
12/28/201616:56BWAurinia Closes US$28 Million Financing
12/22/201605:00BWAurinia Announces US$25.0 Million Bought Deal Financing
12/19/201615:05BWAurinia Announces Long-Term Manufacturing Collaboration..
12/13/201607:00BWAurinia Confirms Receipt of FDA End of Phase 2 Meeting..
12/12/201615:05BWAurinia Announces Appointment of Biotech Industry Leader..
11/21/201608:27BWAurinia Highlights Renal Function Data from Global Phase IIb..
11/16/201607:00BWAurinia Highlights Speed of Remission from Global Phase IIb..
11/10/201612:35BWAurinia Pharmaceuticals to Present at Stifel 2016 Healthcare..
11/09/201616:05BWAurinia Establishes At-The-Market Facility
11/04/201617:55BWAurinia Reports Third Quarter 2016 Financial Results and..
11/03/201607:09PRNCAL'OCRCVM permet la reprise de la négociation - AUP
11/03/201607:07PRNCAIIROC Trade Resumption - AUP
11/02/201615:59PRNCASuspension de la négociation par l'OCRCVM - AUP
11/02/201615:56PRNCAIIROC Trading Halt - AUP
11/02/201615:42BWAurinia Announces Plans for Single Phase III Clinical Trial..
10/24/201616:15BWAurinia Announces Acceptance of Late-Breaking Voclosporin..
See more news about this stock »
Your Recent History
TSX
BCE
BCE Inc
TSX
IVN
Ivanhoe Mi..
FX
CADUSD
Canadian D..
USOTC
XUII
Xumanii In..
FX
EURCAD
Euro vs Ca..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20170921 13:55:38